Home
About CQCO
Signature Events
Awards
Program Reviews
Publications
Quality Index
Key Findings
Indicators by LHIN
Patient Journey
Cancer in Ontario
Comparisons
Quality Dimensions
All Indicators
Cancer System Quality Index (CSQI) 2012
Safe
Rating: Good. Some processes and standards for a safe cancer system are in place. However, we need better measures of safety from the patient's perspective.
Thoracic Cancer Surgery Standards and Post-Surgical Mortality
HPB Cancer Surgery Standards and Post-Surgical Mortality
Emergency Department Visits after Adjuvant Chemotherapy
Systemic Treatment Safety
Breast Cancer Screening: Follow-up of abnormal results
Cervical Cancer Screening: Follow-Up of abnormal results
Colorectal Cancer Screening: Follow-up of abnormal results
Synoptic Pathology Reporting
Reporting Stage at Diagnosis
Lymph node sampling in colon cancer
Quality of Pathology & Cancer Surgery: Margin Status in Prostate Cancer Surgery
Quality of Pathology & Cancer Surgery: Margin Status in Rectal Cancer Surgery
Multidisciplinary Cancer Conferences
Treating NSC Lung Cancer According to Guidelines
Treating Stage III Colon Cancer According to Guidelines
Consultation with a Medical Oncologist
Radiation Treatment Utilization
Intensity Modulated Radiation Therapy Utilization (IMRT Utilization)
Breast Cancer Screening (Mammography) Participation
Cervical Cancer Screening (Pap test) Participation
Colorectal Cancer Screening Participation (FOBT, Flexible Sigmoidoscopy, Colonoscopy)
Wait Times for Cancer Surgery
Wait Times for Radiation Treatment
Wait Times for Systemic Treatment
Patient Experience with Outpatient Cancer Care
Symptom Assessment and Management
Integrated Cancer Screening Participation
Wait Times from Diagnosis to Chemotherapy
Wait Times from Surgery to Chemotherapy
Radiation Machine Efficiency
Chemotherapy in the Last Two Weeks of Life
End-of-Life Care
Lung Cancer Incidence by Sociodemographic Status (SDF)
Selected Modifiable Risk Factors (by sociodemographic factors)
Treating Stage III Colon Cancer According to Guidelines (by age, by sex)
Consultation with a Medical Oncologist (by age)
Breast Cancer Screening Participation (Mammography by Socio-Economic Status and by Age)
Cervical Cancer Screening Participation (Pap test by Socio-Economic Status and by Age)
Colorectal Cancer Screening Participation (FOBT, flexible Sigmoidoscopy, Colonoscopy only by Socio-Economic Status)
Integrated Cancer Screening Participation (by Socio-Economic Status)
Chemotherapy in the Last Two Weeks of Life (by age)
Effective
Rating: Very Good. Cancer services are generally effective and evidence-based.
Accessible
Rating: Good. More Ontarians are accessing the services they need but efforts need to continue.
Responsive
Rating: Fair. Ontario's cancer system needs to focus more on patients' and survivors' quality of life, both during and after active treatment.
Equitable
Rating: Poor. Cancer burden is still higher among those with lower socio-economic status. More work needs to be done using a whole-of-society approach to ensure equity.
Integrated
Rating: Poor. We have better data for measures that bridge across the cancer system, but more improvement is needed to ensure a seamless journey for patients and survivors.
Efficient
Rating: Fair. We need to better measure cost efficiency and value for money, while maintaining good health outcomes for all Ontarians.
*
Very Good
Good
Fair
Poor
Incomplete Data
*
These symbols provide an overall assessment of cancer system performance for each dimension of quality. They include at an aggregate level, an assessment of performance over time, performance against annual programmatic targets, jurisdictional comparisons and/or clinical aims for those measures available in the index. Breadth and depth of indicators across the patient continuum and type of indicator are taken into account in the assessment.
If I got a phone call today from someone who was newly diagnosed, I think I would reassure them by telling them that the treatments today are much better, first of all, than they were 23 years ago.
John,
diagnosed with non-Hodgkin lymphoma at age 46
Special Focus
View the webcast of the CSQI 2012 launch event
Ontario's 8th annual update on the performance of the cancer system
The first of its kind in North America, the CSQI:
Tracks Ontario’s progress against cancer
Shows where quality and performance improvements are needed
Reports on 32 evidence-based quality measures covering every aspect of cancer control, from cancer prevention to end-of-life care
50% Percentage of lung cancer patients diagnosed at Stage IV, when survival is poor. 12% Percentage of Grade 10–12 students smoke. 90% Approximate percentage of lung cancer directly related to tobacco use. 72% Percentage of eligible women aged 20–69 screened for cervical cancer in Ontario in 2008–2010. 95% Percentage of head and neck cancer patients treated with Intensity Modulated Radiation Therapy (IMRT) in 2011. 55,000 Approximate number of cancer surgeries in Ontario in 2011. 71,926 Estimated number of new cancer cases that will be diagnosed in Ontario in 2012. 79% Approximate percentage of deaths in Ontario caused by chronic diseases, including cancers.
Home
|
Media
|
Contact Us
|
Site Map
|
Terms & Conditions